AAP recommends HPV vaccine for boys; Virginia lifts the law mandating the HPV vax in teens;

> Aluminum-based adjuvants may cause long-term immune system damage in pediatric patients. Press release

> NIH has joined with Aeras and Crucell to support a Phase II proof-of-concept clinical trial of a tuberculosis vaccine candidate. Press release

> Virginia has lifted the law mandating HPV vaccination in teens. Article

> Inovio's flu vaccine has shown positive signs in animal studies. Press release

> University of Oslo researchers are developing a DNA vaccine administered using an electrical pulse that could have potential against viral infections and cancer. Press release

> The American Academy of Pediatrics is recommending that all 11- and 12-year-old boys receive the three-dose vaccine for the human papillomavirus. Press release

> Researchers at the University of Georgia are untangling the ways that influenza viruses replicate and hope this might lead to new treatments. Story

And Finally... Targovax has secured NOK 13 million ($2.2 million) to support the development of TG01, its therapeutic vaccine for pancreatic cancer. Press release

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.